메뉴 건너뛰기




Volumn 25, Issue 4, 2010, Pages 1183-1191

Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease

Author keywords

Cardiovascular disease; Chronic kidney disease; Mortality; P cresylsulphate; Uraemic toxins

Indexed keywords

ANTIDIABETIC AGENT; FREE 4 CRESYLSULFATE; INSULIN; PARA CRESOL; SULFATE; SULFUR ACID DERIVATIVE; TOTAL 4 CRESYLSULFATE; UNCLASSIFIED DRUG;

EID: 77950234472     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp592     Document Type: Article
Times cited : (372)

References (34)
  • 1
    • 0033653746 scopus 로고    scopus 로고
    • Cardiovascular disease in chronic renal insufficiency
    • Levin A, Foley RN. Cardiovascular disease in chronic renal insufficiency. Am J Kidney Dis 2000; 36: S24-S30
    • (2000) Am J Kidney Dis , vol.36
    • Levin, A.1    Foley, R.N.2
  • 2
    • 20844434983 scopus 로고    scopus 로고
    • Chronic kidney disease as cause of cardiovascular morbidity and mortality
    • Vanholder R, Massy Z, Argiles A, et al. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant 2005; 20: 1048-1056
    • (2005) Nephrol Dial Transplant , vol.20 , pp. 1048-1056
    • Vanholder, R.1    Massy, Z.2    Argiles, A.3
  • 3
    • 0035989794 scopus 로고    scopus 로고
    • Cardiovascular disease risk factors in chronic renal insufficiency
    • Sarnak MJ, Coronado BE, Greene T, et al. Cardiovascular disease risk factors in chronic renal insufficiency. Clin Nephrol 2002; 57: 327-335
    • (2002) Clin Nephrol , vol.57 , pp. 327-335
    • Sarnak, M.J.1    Coronado, B.E.2    Greene, T.3
  • 4
    • 0032838784 scopus 로고    scopus 로고
    • Pathophysiologic effects of uraemic retention solutes
    • Vanholder R, De Smet R. Pathophysiologic effects of uraemic retention solutes. J Am Soc Nephrol 1999; 10: 1815-1823
    • (1999) J Am Soc Nephrol , vol.10 , pp. 1815-1823
    • Vanholder, R.1    De Smet, R.2
  • 5
    • 0028297796 scopus 로고
    • Uraemic toxicity: The middle molecule hypothesis revisited
    • Vanholder R, De Smet R, Hsu C, et al. Uraemic toxicity: the middle molecule hypothesis revisited. Semin Nephrol 1994; 14: 205-218
    • (1994) Semin Nephrol , vol.14 , pp. 205-218
    • Vanholder, R.1    De Smet, R.2    Hsu, C.3
  • 7
    • 0017297766 scopus 로고
    • Study of the intestinal tyrosine metabolism using stable isotopes and gas chromatography-mass spectrometry
    • Curtius HC, Mettler M, Ettlinger L. Study of the intestinal tyrosine metabolism using stable isotopes and gas chromatography-mass spectrometry. J Chromatogr 1976; 126: 569-580
    • (1976) J Chromatogr , vol.126 , pp. 569-580
    • Curtius, H.C.1    Mettler, M.2    Ettlinger, L.3
  • 8
    • 0030867709 scopus 로고    scopus 로고
    • Genetic and environmental factors associated with variation of human xenobiotic glucuronidation and sulfa-tion
    • Burchell B, Coughtrie MW. Genetic and environmental factors associated with variation of human xenobiotic glucuronidation and sulfa-tion. Environ Health Perspect 1997; 105: 739-747
    • (1997) Environ Health Perspect , vol.105 , pp. 739-747
    • Burchell, B.1    Coughtrie, M.W.2
  • 10
    • 0031786689 scopus 로고    scopus 로고
    • A sensitive HPLC method for the quantification of free and total p-cresol in patients with chronic renal failure
    • De Smet R, David F, Sandra P, et al. A sensitive HPLC method for the quantification of free and total p-cresol in patients with chronic renal failure. Clin Chim Acta 1998; 278: 1-21
    • (1998) Clin Chim Acta , vol.278 , pp. 1-21
    • De Smet, R.1    David, F.2    Sandra, P.3
  • 11
    • 0028962014 scopus 로고
    • Mechanisms of urae-mic inhibition of phagocyte reactive species production: Characterization of the role of p-cresol
    • Vanholder R, De Smet R, Waterloos MA, et al. Mechanisms of urae-mic inhibition of phagocyte reactive species production: characterization of the role of p-cresol. Kidney Int 1995; 47: 510-517
    • (1995) Kidney Int , vol.47 , pp. 510-517
    • Vanholder, R.1    De Smet, R.2    Waterloos, M.A.3
  • 12
    • 18744385213 scopus 로고    scopus 로고
    • P-cresol, a uraemic toxin, decreases endothelial cell response to inflammatory cytokines
    • Dou L, Cerini C, Brunet P, et al. P-cresol, a uraemic toxin, decreases endothelial cell response to inflammatory cytokines. Kidney Int 2002; 62: 1999-2009
    • (2002) Kidney Int , vol.62 , pp. 1999-2009
    • Dou, L.1    Cerini, C.2    Brunet, P.3
  • 13
    • 0037371201 scopus 로고    scopus 로고
    • Toxicity of free p-cresol: A prospective and cross-sectional analysis
    • De Smet R, Van Kaer J, Van Vlem B, et al. Toxicity of free p-cresol: a prospective and cross-sectional analysis. Clin Chem 2003; 49: 470-478
    • (2003) Clin Chem , vol.49 , pp. 470-478
    • De Smet, R.1    Van Kaer, J.2    Van Vlem, B.3
  • 14
    • 42949119698 scopus 로고    scopus 로고
    • Free p-cresol is associated with cardiovascular disease in hemodialysis patients
    • Meijers BK, Bammens B, De Moor B, et al. Free p-cresol is associated with cardiovascular disease in hemodialysis patients. Kidney Int 2008; 73: 1174-1180
    • (2008) Kidney Int , vol.73 , pp. 1174-1180
    • Meijers, B.K.1    Bammens, B.2    De Moor, B.3
  • 15
    • 33644872268 scopus 로고    scopus 로고
    • Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients
    • Bammens B, Evenepoel P, Keuleers H, et al. Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. Kidney Int 2006; 69: 1081-1087
    • (2006) Kidney Int , vol.69 , pp. 1081-1087
    • Bammens, B.1    Evenepoel, P.2    Keuleers, H.3
  • 16
    • 23044487722 scopus 로고    scopus 로고
    • Gas chromatographic-mass spectrometric analysis for measurement of p-cresol and its conjugated metabolites in uraemic and normal serum
    • de Loor H, Bammens B, Evenepoel P, et al. Gas chromatographic-mass spectrometric analysis for measurement of p-cresol and its conjugated metabolites in uraemic and normal serum. Clin Chem 2005; 51: 1535-1538
    • (2005) Clin Chem , vol.51 , pp. 1535-1538
    • De Loor, H.1    Bammens, B.2    Evenepoel, P.3
  • 17
    • 33846659447 scopus 로고    scopus 로고
    • P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production
    • Schepers E, Meert N, Glorieux G, et al. P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production. Nephrol Dial Transplant 2007; 22: 592-596
    • (2007) Nephrol Dial Transplant , vol.22 , pp. 592-596
    • Schepers, E.1    Meert, N.2    Glorieux, G.3
  • 18
    • 70350031206 scopus 로고    scopus 로고
    • The uraemic retention solute p-cresyl sulfate and markers of endothelial damage
    • Meijers BK, Van Kerckhoven S, Verbeke K, et al. The uraemic retention solute p-cresyl sulfate and markers of endothelial damage. Am J Kidney Dis 2009; 54: 891-901
    • (2009) Am J Kidney Dis , vol.54 , pp. 891-901
    • Meijers, B.K.1    Van Kerckhoven, S.2    Verbeke, K.3
  • 19
    • 58449118342 scopus 로고    scopus 로고
    • Effective removal of protein-bound uraemic solutes by different convective strategies: A prospective trial
    • Meert N, Eloot S, Waterloos MA, et al. Effective removal of protein-bound uraemic solutes by different convective strategies: a prospective trial. Nephrol Dial Transplant 2009; 24: 562-570
    • (2009) Nephrol Dial Transplant , vol.24 , pp. 562-570
    • Meert, N.1    Eloot, S.2    Waterloos, M.A.3
  • 20
    • 39449112419 scopus 로고    scopus 로고
    • Estimating GFR using serum cystatin C alone and in combination with serum creatinine: A pooled analysis of 3,418 individuals with CKD
    • Stevens LA, Coresh J, Schmid CH, et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 2008; 51: 395-406
    • (2008) Am J Kidney Dis , vol.51 , pp. 395-406
    • Stevens, L.A.1    Coresh, J.2    Schmid, C.H.3
  • 21
    • 0036176161 scopus 로고    scopus 로고
    • K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
    • K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-S266
    • (2002) Am J Kidney Dis , vol.39
  • 22
    • 0036054609 scopus 로고    scopus 로고
    • Carotid plaques, but not common carotid intima-media thickness, are independently associated with aortic stiffness
    • Zureik M, Temmar M, Adamopoulos C, et al. Carotid plaques, but not common carotid intima-media thickness, are independently associated with aortic stiffness. J Hypertens 2002; 20: 85-93
    • (2002) J Hypertens , vol.20 , pp. 85-93
    • Zureik, M.1    Temmar, M.2    Adamopoulos, C.3
  • 23
    • 0029087202 scopus 로고
    • Assessment of arterial dis-tensibility by automatic pulse wave velocity measurement. Validation and clinical application studies
    • Asmar R, Benetos A, Topouchian J, et al. Assessment of arterial dis-tensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension 1995; 26: 485-490
    • (1995) Hypertension , vol.26 , pp. 485-490
    • Asmar, R.1    Benetos, A.2    Topouchian, J.3
  • 24
    • 0030806999 scopus 로고    scopus 로고
    • New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: A 25-year follow-up study
    • Kauppila LI, Polak JF, Cupples LA, et al. New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis 1997; 132: 245-250
    • (1997) Atherosclerosis , vol.132 , pp. 245-250
    • Kauppila, L.I.1    Polak, J.F.2    Cupples, L.A.3
  • 25
    • 33750606026 scopus 로고    scopus 로고
    • Confounding: Propensity score adjustment
    • Fitzmaurice G. Confounding: propensity score adjustment. Nutrition 2006; 22: 1214-1216
    • (2006) Nutrition , vol.22 , pp. 1214-1216
    • Fitzmaurice, G.1
  • 26
    • 3543047979 scopus 로고    scopus 로고
    • P-cresol, a uraemic retention solute, alters the endothelial barrier function in vitro
    • Cerini C, Dou L, Anfosso F, et al. P-cresol, a uraemic retention solute, alters the endothelial barrier function in vitro. Thromb Haemost 2004; 92: 140-150
    • (2004) Thromb Haemost , vol.92 , pp. 140-150
    • Cerini, C.1    Dou, L.2    Anfosso, F.3
  • 27
    • 1642480079 scopus 로고    scopus 로고
    • The uraemic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair
    • Dou L, Bertrand E, Cerini C, et al. The uraemic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair. Kidney Int 2004; 65: 442-451
    • (2004) Kidney Int , vol.65 , pp. 442-451
    • Dou, L.1    Bertrand, E.2    Cerini, C.3
  • 28
    • 33745725902 scopus 로고    scopus 로고
    • Acarbose treatment lowers generation and serum concentrations of the protein-bound solute p-cresol: A pilot study
    • Evenepoel P, Bammens B, Verbeke K, et al. Acarbose treatment lowers generation and serum concentrations of the protein-bound solute p-cresol: a pilot study. Kidney Int 2006; 70: 192-198
    • (2006) Kidney Int , vol.70 , pp. 192-198
    • Evenepoel, P.1    Bammens, B.2    Verbeke, K.3
  • 29
    • 33645231323 scopus 로고    scopus 로고
    • A multicenter, randomized, double-blind, placebo-controlled, dose-ranging study of AST-120 (Kremezin) in patients with moderate to severe CKD
    • Schulman G, Agarwal R, Acharya M, et al. A multicenter, randomized, double-blind, placebo-controlled, dose-ranging study of AST-120 (Kremezin) in patients with moderate to severe CKD. Am J Kidney Dis 2006; 47: 565-577
    • (2006) Am J Kidney Dis , vol.47 , pp. 565-577
    • Schulman, G.1    Agarwal, R.2    Acharya, M.3
  • 30
    • 0027249628 scopus 로고
    • Suppressive effect of an oral sorbent on the accumulation of p-cresol in the serum of experimental uraemic rats
    • Niwa T, Ise M, Miyazaki T, et al. Suppressive effect of an oral sorbent on the accumulation of p-cresol in the serum of experimental uraemic rats. Nephron 1993; 65: 82-87
    • (1993) Nephron , vol.65 , pp. 82-87
    • Niwa, T.1    Ise, M.2    Miyazaki, T.3
  • 31
    • 34248194989 scopus 로고    scopus 로고
    • AST-120, an oral adsorbent, delays the initiation of dialysis in patients with chronic kidney diseases
    • Ueda H, Shibahara N, Takagi S, et al. AST-120, an oral adsorbent, delays the initiation of dialysis in patients with chronic kidney diseases. Ther Apher Dial 2007; 11: 189-195
    • (2007) Ther Apher Dial , vol.11 , pp. 189-195
    • Ueda, H.1    Shibahara, N.2    Takagi, S.3
  • 32
    • 54249083025 scopus 로고    scopus 로고
    • AST-120 treatment in pre-dial-ysis period affects the prognosis in patients on hemodialysis
    • Ueda H, Shibahara N, Takagi S, et al. AST-120 treatment in pre-dial-ysis period affects the prognosis in patients on hemodialysis. Ren Fail 2008; 30: 856-860
    • (2008) Ren Fail , vol.30 , pp. 856-860
    • Ueda, H.1    Shibahara, N.2    Takagi, S.3
  • 34
    • 0142120730 scopus 로고    scopus 로고
    • Novel risk markers and clinical practice
    • Manolio T. Novel risk markers and clinical practice. N Engl J Med 2003; 349: 1587-1589
    • (2003) N Engl J Med , vol.349 , pp. 1587-1589
    • Manolio, T.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.